Rx Pak Division of McKesson Corporation recalls Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by: Aenov…

Recall date

January 16, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-1007-2019

FDA classification

Class II

Brand / firm

Rx Pak Division of McKesson Corporation

Sold / distributed

Product was distributed to 5 major distributors who may have further distributed the product throughout the United States.

Why it was recalled

Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by: Aenova Holding GmBh, Miami, Fl 33186, NDC 63739-0478-10